FDA clears Disetronic's multi-use pump:
This article was originally published in Clinica
Disetronic has received 510(k) clearance from the US FDA to market its Multifuse peristaltic pump. The device is used mainly to administer analgesia, chemotherapy and antibiotics and provides physicians with a choice of applications in a single system, says the Burgdorf-based Swiss company. German company B Braun Melsungen, Disetronic's marketing partner for Multifuse, plans to launch the system in the US shortly.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.